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 Rhipicephalus microplus is a cattle ectoparasite found in tropical and subtropical 
regions around the world with great impact on livestock production. R. microplus can also 
harbor pathogens, such as Babesia sp. and Anaplasma sp. which further compromise 
cattle production. Blood meal acquisition and digestion are key steps for tick 
development. In ticks, digestion takes place inside midgut cells and is mediated by 
aspartic and cysteine peptidases and, therefore, regulated by their inhibitors. Cystatins 
are a family of cysteine peptidases inhibitors found in several organisms and have been 
associated in ticks with blood acquisition, blood digestion, modulation of host immune 
response and tick immunity. In this work, we characterized a novel R. microplus type 1 
cystatin, named Rmcystatin-1b. The inhibitor transcripts were found to be highly 
expressed in the midgut of partially and fully engorged females and they appear to be 
modulated at different days post-detachment. Purified recombinant Rmcystatin-1b 
displayed inhibitory activity towards typical cysteine peptidases with high affinity. 
Moreover, rRmcystatin-1b was able to inhibit native R. microplus cysteine peptidases and 
RNAi-mediated knockdown of the cystatin transcripts resulted in increased proteolytic 
activity. Moreover, rRmcystatin-1b was able to interfere with B. bovis growth in vitro. 
Taken together our data strongly suggest that Rmcystatin-1b is a regulator of blood 




 The R. microplus is one of the most relevant ectoparasites in the tropical and 
subtropical regions of the globe due to its impact on livestock production (Grisi et al., 
2014; Jongejan et al., 2004). Moreover, R. microplus also acts as a vector of the etiologic 
agents of anaplasmosis and babesiosis (de Castro et al., 1997), which can further impair 
cattle production. Tick control relies mainly on acaricides, substances with several 









populations (Angus, 1996; Uilenberg, 1996), urging the need for the development of 
alternative control methods. 
 Blood meal acquisition and digestion are key steps in the tick life cycle and, in 
ticks, digestion begins when red blood cells are disrupted in the midgut lumen by a yet-
to-be-discovered proteolytic event (Soneshine, 2013). Then, proteins are transported to 
or taken up by midgut cells (Lara et al., 2005) where they are processed by a multi-
enzymatic cascade composed of aspartic and cysteine peptidases (Horn et al., 2009; 
Sojka et al., 2013; Sojka et al., 2016). Therefore, it has been proposed that aspartic and 
cysteine peptidase inhibitors can act as regulators of the digestion process. Not 
surprisingly, in R. microplus, cysteine and aspartic peptidases have been previously 
identified and implicated in blood digestion (Clara et al., 2011; Cruz et al., 2010) as well 
as cystatins (Cardoso et al., 2017). 
Cysteine peptidase inhibitors are classified into the cystatin superfamily based on 
their primary features (Barret et al., 1985; Rawlings et al., 2018). In the past years, several 
type 2 cystatins from ticks were identified and associated with different physiological 
processes, such as blood feeding (Karim et al., 2005; Yamaji et al., 2009), parasite-host 
relantionship (Kotsyfakis et al., 2006; Salat et al., 2010), blood digestion (Cardoso et al., 
2017; Yamaji et al., 2010) and immune response (Lu et al., 2014; Zhou et al., 2006). On 
the other hand, only a handful of type 1 cystatins have been characterized. Bmcystatin 
was the first type 1 cystatin described in R. microplus and was shown to be located in 
different tick tissues. Since the recombinant Bmcystatin was able to inhibit VTDCE (vitellin 
degrading cysteine endopeptidase), it was proposed that Bmcystatin plays a role during 
tick embryogenesis (Lima et al., 2006). In Haemaphysalis longicornis tick, a type-1 
cystatin (Hlcys-1) identified in midgut cells was able to inhibit H. longicornis cathepsin L-
like A (HlCPL-A) (Yamaji et al., 2010), indicating a possible role in protein digestion 
control. 
Taking into account the lack of knowledge about type-1 cystatins and their role in 
tick physiological processes, in this work, we describe and characterize the second type 


















2. Materials and methods 
2.1. Bioinformatics analysis: A R. microplus transcriptome (SRA accession numbers: 
SRX484287, SRX484284, SRX484280 and SRX484277) was assembled and annotated 
as described (Karim et al., 2011). The putative Rmcystatin-1b DNA sequence was 
submitted to a domain analysis with PFAM (https://pfam.xfam.org/) and detection of a 
putative signal peptide was carried out with SignalP 4.1 
(http://www.cbs.dtu.dk/services/SignalP/) (Cruz et al., 2017). The theoretical molecular 
weight and isoelectric point were estimated using the Compute pI/MW tool 
(https://web.expasy.org/compute_pi/) (Wilkins et al., 1999). An amino acid alignment was 
performed with Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al., 
2011) and edited with BioEdit software (Hall 1999). An unrooted phylogenetic tree was 
constructed with MEGA X (Kumar et al., 2018) using the cystatins sequences from Ixodes 
scapularis (AAY66685.1, AAM93646.1, AAY66864.1, EEC02341.1, EEC07265.1, 
EEC07262.1, KX513947, KX513948 and XP_029841129.1), H. longicornis (ABZ89553.1, 
ABC94582.1, ABZ89554.1 and BAI59105.1), R. microplus (ABG36931.1, AIX97454.1, 
KC816580.1 and KC816581), Dermacentor variabilis (ACF35512.1) and Rmcystatin-1b. 
The phylogenetic tree was constructed using the Neighbor-joining method based on the 
alignment of 155 residues (gaps included) from the cystatin sequences with 500 bootstrap 
replicates. 
2.2. Total RNA and protein extraction from tick tissues: Partially and fully fed R. 
microplus females obtained from a laboratory colony (Porto Alegre strain, Porto Alegre, 
Brazil) were reared on Hereford cattle (Bos taurus taurus) brought from a naturally tick-
free area and maintained in insulated pens (Reck et al., 2009). Ticks were washed with 
70% ethanol and ultrapure water and dissected. Midgut, ovary, salivary glands and 
hemocytes were collected and suspended in 0.5 mL of Trizol reagent (Invitrogen, CA, 
USA). Total RNA extraction was performed using manufacturer’s instructions and cDNA 
was prepared using the Improm-II Reverse Transcription System (Promega, WI, USA). A 
segment of tick midgut was also suspended in 0.5 mL of PBS, disrupted and centrifuged 










2.3. DNA amplification and cloning: Rmcystatin-1b full-length ORF was amplified by 
PCR using 100 μM dNTPs, 1.5 mM MgCl2, 5 U Taq DNA polymerase (Sinapse, SP, BR), 
25 pmol of each primer (Rmcystatin-1b.Nco.FW and Rmcystatin-1b.BamHI.RV - Suppl. 
Table 1) and 1 µL of a midgut cDNA preparation from fully engorged R. microplus females. 
The forward and reverse primers contained terminal NcoI and BamHI restriction sites, 
respectively. Reactions were submitted to 94C – 10 min, followed by 25 cycles of 94C 
– 30 s, 55C – 60 s, 72C – 60 s and a final extension at 72C for 10 min. PCR products 
were observed in a 1% agarose gel and purified with QIAEXII extraction kit (QIAGEN, 
Hilden, DE). A purified Rmcystatin-1b amplicon and pET14b were digested with NcoI 
(Fermentas, Vilnius, LT) and BamHI (Fermentas, Vilnius, LT) overnight at 37°C, purified 
with QIAEXII kit (QIAGEN, Hilden, DE) and subjected to ligation with T4 ligase (Promega, 
WI, USA) overnight at 16°C. Finally, the ligation product was used in the transformation 
of Escherichia coli DH5α and the positive clones were confirmed by colony PCR using T7 
promoter and terminator primers and sequenced using a Big Dye Terminator cycle 
sequencing kit (Applied Biosystems, Warrington, UK) in an ABI Prism 3130 automated 
sequencer (Applied Biosystems, Warrington, UK).  
2.4. Expression and purification: Rmcystatin-1b expression was carried out in E. coli 
BL21 pLysS strain induced with 1 mM IPTG at 37°C. After 16 h of induction, cells were 
collected by centrifugation (10 min, 3000 x g at 4°C) and suspended in 100 mL of 50 mM 
Tris-HCl pH 8.0. Bacterial lysis was carried out using a French pressure cell press system 
(Thermo, MA, USA); the bacterial suspension was submitted three times to a 2000 psi 
pressure. After lysis the sample was centrifuged (10 min, 12000 x g at 4°C) and the 
supernatant collected and submitted to ionic exchange chromatography with a HiPrep Q 
resin. The resin was previously equilibrated with 50 mM Tris-HCl pH 8.0 and protein 
elution was carried out with a linear gradient of NaCl (0 to 1 M) in 50 mM Tris-HCl pH 8.0. 
Eluted fractions that presented inhibitory activity towards human cathepsin L (item 2.7) 
were pooled, dialyzed against 50 mM Tris-HCl pH 8.0 and submitted to size exclusion 










2.5. Rmcystatin-1b primary structure analysis by mass spectrometry: Approximately 
40 µg of rRmcystatin-1b were precipitated with chloroform/methanol (Wessel and Flugge, 
1984). The pellet was resuspended in 100 mM Tris HCl pH 7.0 containing 8 M urea, 
disulfide bonds were reduced in 5 mM dithiothreitol (DTT) for 20 min at 37 C and then 
cysteines were alkylated in 25 mM iodoacetamide (IAM) for 20 min at room temperature 
in the dark. Urea was diluted to 2 M with 100 mM Tris HCl pH 7.0, trypsin was added at 
a mass ratio of 1:100 (trypsin/protein) and the sample was incubated overnight at 37°C. 
Formic acid was added to finish the reaction (5% v/v, final concentration). Peptides were 
separated on an in-house made 20 cm reverse-phase (5 µm ODSAQ C18, Yamamura 
Chemical Lab, Japan) using a nanoUPLC (nanoLC Ultra 1D plus, Eksigent, USA) 
connected to a LTQ-XL Orbitrap Discovery hybrid instrument (Thermo Fisher Scientific) 
through a nanoelectrospray ion source (Thermo Fisher Scientific). The flow rate was set 
to 300 nL min-1 in a 60 minutes reverse-phase gradient. The mass spectrometer was 
operated in a data-dependent mode, with full MS1 scan collected in the Orbitrap, with m/z 
range of 400-1600 at 30,000 resolution. The eight most abundant ions per scan were 
selected to CID MS2 in the ion trap. Raw data were searched against a non-redundant 
database containing forward and reverse E. coli BL21 pLysS proteome and Rmcystatin-
1b sequence using Comet (Eng et al., 2013) through PatternLab for Proteomics platform 
(Carvalho et al., 2016). The validity of the peptide-spectra matches (PSMs) generated 
was assessed using Patternlab´s module SEPro (Carvalho et al., 2016) with a false 
discovery rate of 1% based on the number of decoys. 
2.6. RT-qPCR: Rmcystatin-1b mRNA levels were quantified in different tissues of partially 
and fully engorged R. microplus females by RT-qPCR. Reactions were prepared with 6 
µL of SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK), 1 µL of the 
cDNA preparation diluted 5 times and 200 nM of each primer (Suppl. Table 1) in a final 
volume of 12 µL. Reactions were carried out in a Step-One Plus equipment (Applied 
Biosystems, Warrington, UK), with 40 cycles (95°C - 1 min, 60°C - 1 min and 72°C - 1 
min). The relative quantification was determined by the 2-ΔΔCt method (Livak and 
Schimttgen, 2011) and the elongation factor 1α gene was used as endogenous control 
(Nijhof et al., 2009). Relative quantification of Rmcystatin-1b transcripts in cDNA from 









while in fully engorged, in relation to hemocytes. Rmcystatin-1b transcripts in the midgut 
at different time points were compared to partially engorged ticks (PF). 
2.7. Determination of the inhibitory constant (Ki): Human cathepsin L (EC 3.4.22.15), 
cathepsin B (EC 3.4.22.1) and BmCL1 previously prepared in our laboratory as described 
(Clara et al., 2011), papain (EC.3.4.22.1) (Calbiochem, USA) and recombinant B. bovis 
cysteine peptidase (XP_001612131) (Lu et al., unpublished data) were incubated in 50 
mM sodium acetate buffer pH 5.0 containing DTT (1 mM) for 10 min at 37°C and different 
concentrations of rRmcystatin-1b were added. Proteolytic activity was monitored by 
fluorescence (380 nm excitation/ 460 nm emission) after addition of fluorogenic substrate 
Z-FR-AMC (4 mM) for assays with cathepsin L, papain, BmCL1 and B. bovis cysteine 
peptidase or Z-RR-AMC (4 mM) for cathepsin B, for 30 min at 37°C. The inhibitory 
constants were determined by fitting the non-linear regression model according to the 
Morrison’s equation (Morrison, 1969) using the Grafit 5.0.11 software (Erithacus Software 
Limited). 
2.8. Proteolytic activity of R. microplus midgut: Crude protein extracts from midgut 
(10 µg) of R. microplus obtained at 24, 48, 72, 96, 120 and 144 h post detachment (hpd) 
were incubated in 50 mM sodium acetate buffer pH 5.0 containing DTT (1 mM) for 10 min 
at 37°C, following the addition of substrates Z-FR-AMC (4 mM) or Z-RR-AMC (4 mM). 
Proteolytic activity was monitored by fluorescence (380 nm excitation/ 460 nm emission) 
for 15 min at 37°C. The proteolytic activity of midguts from 48 and 120 hpd was also 
evaluated in the presence of different inhibitors  (E64, CA-074, rRmcystatin-1b, EDTA 
and APMSF). The initial rate was determined by linear regression of fluorescence (RFU) 
per time (min) and the residual activity by the ratio between the proteolytic activity in the 
presence of the inhibitor and the control reaction (without inhibitor). 
2.9. Rmcystatin-1b knock-down by RNA interference (RNAi): Rmcystatin-1b and GFP 
double strand RNA (dsRmcys1b and dsGFP) were synthesized with the T7 Ribomax 
RNAi System kit (Promega, WI, USA) following the manufacturer’s instructions and 10 µg 
of dsRNA were injected in the hemolymph of ticks 72 hpd. After 24 h of dsRNA injection, 
the midguts of 6 ticks were individually dissected and stored in Trizol reagent (Invitrogen, 









Rmcystatin-1b knock-down was carried out by RT-qPCR as described in item 2.6 and 
proteolytic activity from the midgut of dsRNA-injected ticks was measured as described 
in 2.8. 
2.10. Effect of rRmcystatin-1b on B. bovis growth in in vitro culture: B. bovis S2P 
strain in vitro cultures were maintained in microaerophilous stationary phase (MASP) as 
described (Levy and Ristic, 1980) with a 10% hematocrit. When the percentage of 
infected red blood cells (RBC) reached 2%, parasites were transferred to a 96 well-plate 
containing complete culture medium including 40% bovine serum, 5% RBC to a final 
percentage of parasitized RBC of 0.2% and supplemented with 15 µL of BSA or 
rRmcystatin-1b (25 µM) in 15 µL. Every 24 h the medium was replaced and 5 µL of packed 
erythrocytes were collected from the bottom of each well and smeared onto glass slides, 
which were then Giemsa-stained and observed by light microscopy. The percentage of 
infected RBC was determined 24, 48 and 72 h by counting 3000 cells per slide. The 
experiment was conducted in triplicate wells for each time point. 
2.11. Statistical analysis: Rmcystatin-1b RT-qPCR results in different tick tissues, as 
well as the modulation of Rmcystatin-1b transcripts in the midgut at different time points, 
were analyzed with one-way ANOVA followed by Bonferroni’s multiple comparison test. 
All RT-qPCR tests were performed using the ΔCt data as described in (Yuan et al., 2006). 
Confirmation of Rmcystatin-1b knock-down by RT-qPCR and proteolytic activity of 
dsRmcystatin-1b and dsGFP injected ticks were tested with Mann-Whitney test. 
Percentages of B. bovis-infected RBC in in vitro culture at 72 h were tested with Mann-
Whitney test. The significant level for statistical differences was set at p < 0.05 and all 










3.1. Primary structure analysis: The complete Rmcystatin-1b nucleotide sequence was 
identified in a R. microplus transcriptome (SRA SRX484287, SRX484284, SRX484280 
and SRX484277) and comprises an ORF of 303 nucleotides (Suppl. Fig. 1). Domain 
analysis of Rmcystatin-1b deduced amino acid sequence revealed the presence of a 
cystatin domain from G8 – Q87 and alignment with other type 1 cystatins showed the 
conserved motifs of the cystatin super-family, the Gly residue in the N-terminal portion 
and the QxVxG motif (Fig. 1A). Rmcystatin-1b did not present the C-terminal PW residues 
neither a putative signal peptide; rendering a mature protein with a molecular weight of 
11.1 kDa and a theoretical pI of 6.27. Phylogenetic analyses of tick cystatins clustered 
Rmcystatin-1b with other type 1 cystatins, closely related to the midgut cystatin 1 from H. 
longicornis (Hlcys-1) (Fig. 1B).  
3.2. Rmcystatin-1b transcription profile in R. microplus tissues: Rmcystatin-1b 
transcripts were mainly located in the midgut of partially and fully engorged females. In 
partially engorged ticks, Rmcystatin-1b transcription in the midgut was 65 times higher in 
relation to salivary glands (Fig. 2A), while in fully engorged ticks, 40 times higher in 
relation to hemocytes (Fig. 2B). Rmcystatin-1b transcripts were also modulated in the 
midgut at different hours post-detachment (hpd). Down-regulation was observed between 
24 and 72 hpd, followed by up-regulation between 96 and 144 hpd (Fig. 2C). No 
modulation was found in ovary or salivary glands (Suppl. Fig. 3). 
3.3. Expression, purification and characterization of rRmcystatin-1b: Recombinant 
Rmcystatin-1b was obtained in soluble form in E. coli BL21 pLysS strain (Fig. 3C – lane 
3). After two purification steps, ionic exchange (Fig. 3A) and size exclusion 
chromatography (Fig. 3B), a major 12 kDa protein band was observed (Fig. 3C – lane 5) 
and confirmed to be rRmcystatin-1b by mass spectrometry analysis (Suppl. Table 2 and 
Suppl. Fig. 2). Purified rRmcystatin-1b presented inhibitory activity towards different 
cysteine peptidases (table 1), including a recombinant B. bovis cysteine peptidase 
(XP_001612131) (Ki = 7.48 nM), although the highest affinity was observed for the 









3.4. Effect of rRmcystatin-1b in R. microplus midgut proteolysis: Proteolytic activity 
of R. microplus midgut homogenates at different time points was measured with two 
substrates, and two proteolytic peaks, at 48 hpd and at 120 hpd, were observed (Fig. 4A). 
The proteolytic activities at 48 and 120 hpd were completely inhibited in the presence of 
E-64 (Fig. 4B). rRmcystatin-1b was able to induce a partial inhibition, similar to the 
selective cathepsin B inhibitor CA-074 (Fig. 4C and D), although the highest degree of 
inhibition was observed in the presence of rRmcystatin-1b at 48 hpd. No inhibition was 
observed in the presence of other peptidase inhibitors such as APMSF and EDTA (Fig. 
4E and F) 
3.5. Effect of Rmcystatin-1b gene knock-down on the midgut proteolytic activity: 
RT-qPCR of dsRmcystatin-1b-injected R. microplus revealed a reduction of 50% in 
Rmcystatin-1b transcripts in relation to dsGFP injected ones (Fig. 5A). Moreover, 
dsRmcystatin-1b-injected ticks presented higher proteolytic activity towards Z-FR-AMC 
(Fig. 5B), while no difference was observed towards Z-RR-AMC (Fig. 5C), however this 
activity was already low in the 48 hpd midgut (Fig. 4A). 
3.6 Effect of rRmcystatin-1b in B. bovis culture: The relevance of apicomplexan 
cysteine peptidases for parasite survival and proliferation has already been demonstrated 
(Okubo et al. 2007; Carletti et al. 2016). Therefore, we decided to evaluate the possible 
inhibitory effect of different concentrations of rRmcystatin-1b on B. bovis growth, in which 
50% reduction in the percentage of infected RBC was observed when compared to 
control-treated cultures at 72 h (Fig. 6A). The effect of rRmcystatin-1b (25 µM) was then 
studied at different time points (24, 48 and 72 h), and significant reductions in infected 











 Rmcystatin-1b primary structure presents typical features of the cystatin super 
family, such as an N-terminal Gly residue and a QxVxG motif (Fig. 1A) (Abrahamson et 
al., 1987; Bode et al., 1988; Stubbs et al., 1990). Since the inhibitor lacks both a signal 
peptide and disulfide bridges, it can be classified into the I25A group (Rawlings et al, 
2018). Like other type 1 cystatins, Rmcystatin-1b does not possess the C-terminal PW 
motif (Ibeli et al., 2013; Lima et al., 2006) and the Asn residue relevant for legumain 
inhibition (Suppl. Fig. 4) (Alvarez-Fernandes et al., 1999). Phylogenetic analysis clustered 
Rmcystatin-1b with other type 1 cystatins, closely related to the intracellular cystatin from 
H. longicornis (Hlcys-1) confirming their close molecular phylogenetic relationship (Fig. 
1B). Hlcys-1 was co-localized in midgut cells with the cysteine peptidase cathepsin L-like 
(HlCPL-A) and was able to inhibit the hemoglobinolytic activity of HlCPL-A in vitro. These 
data suggest that Hlcys-1 may act as an endogenous inhibitor of HlCPL-A, thus regulating 
blood digestion in H. longicornis (Yamaji et al., 2010; Zhou et al., 2009). (Yamaji et al., 
2010; Zhou et al., 2009). A similar biological function might be carried out by Rmcystatin-
1b. In addition, Rmcystatin-1b transcripts were found in higher concentrations in the 
midgut of partially and fully engorged females (Fig. 2A and B), substantiating its possible 
role during blood digestion. So far only a handful of type 1 cystatins were biochemically 
described in ticks (Wang et al., 2015; Yamaji et al., 2009; Zhou et al., 2009) and most of 
them were identified in salivary gland transcriptomes (Anderson et al., 2008; Karim et al., 
2015; de Castro et al., 2016; Esteves et al., 2017) suggesting a role in blood acquisition 
rather than in blood digestion. In R. microplus only another type 1 cystatin has been 
previously described and associated with embryogenesis (Lima et al., 2006). 
Although it is well accepted that cysteine peptidases and cystatin interplay can be relevant 
for tick digestion (Schwarz et al., 2012; Sojka et al., 2013) and several putative enzymes 
and inhibitors were identified in the tick midgut by transcriptome studies (Anderson et al., 
2008; Perner et al., 2016), little is known about the temporal dynamics of this interaction. 
In Ixodes ricinus different classes of enzymes responsible for blood digestion have been 
identified (Horn et al., 2009) and shown to be active at different days of feeding (Franta 









days post-detachment revealed a distinct behavior towards different substrates (Fig. 4A), 
in which higher proteolytic activity towards Z-FR-AMC was observed at 48 hpd. 
Interestingly, Rmcystatin-1b transcripts were found to be down-regulated at 48 hpd and 
up-regulated later on (Fig. 2C). Together, these data suggest that enzymes with higher 
affinity for Z-FR-AMC are relevant in the early phase of blood digestion when Rmcystatin-
1b concentrations are low and as digestion progresses, Rmcystatin-1b concentration 
increases, thus regulating such enzymes in a later period.  
To test this hypothesis, we evaluated the proteolytic activity of tick midguts at 48 
and 120 hpd in the presence of different inhibitors (Fig. 4B - F). Notably, purified 
rRmcystatin-1b (Fig. 3) was able to inhibit 67% of the proteolytic activity at 48 hpd and 
56% at 120 hpd, indicating a higher affinity for enzymes present at the early steps post-
detachment. As expected, no inhibitory activity was observed in the presence of APMSF 
(Fig. 4E) or EDTA (Fig. 4E), confirming that the activity observed is from cysteine 
peptidases. Rmcystatin-1b gene knock-down at 96 hpd (Fig. 5A) resulted in an increase 
of proteolytic activity towards Z-FR-AMC (Fig. 5B) but not towards Z-RR-AMC (Fig. 5C), 
moreover rRmcystatin-1b presented higher inhibitory activity towards cathepsin L-Like 
peptidases, such as human cathepsin-L (Ki = 0.41 nM) and BmCL1 (Ki = 0.013 nM), 
rather than cathepsin B (Ki = 6.27 nM) (table 1). Taken together, these data strongly 
suggest that the Rmcystatin-1b target is, preferentially, cathepsin L-Like peptidases, 
which have been previously described in the early phases of digestion in I. Ricinus (Horn 
et al., 2009; Sojka et al., 2013). 
Previous studies have shown that inhibition of cysteine peptidases from 
apicomplexan parasites can interfere with parasite survival (Carletti et al., 2016; Okubo 
et al., 2007). Moreover a type 2 cystatin from H. longicornis (Hlcyst-2), found mainly in 
the midgut of this tick, was able to interfere with B. bovis growth in vitro (Zhou et al., 2006), 
demonstrating the possible interaction between cysteine peptidases from parasites with 
vector cystatins. Since R. microplus is a natural B. bovis vector, we decided to investigate 
the possible role of Rmcystatin-1b during parasite-vector interaction. Although 
rRmcystatin-1b was able to inhibit recombinant B. bovis cysteine peptidase 









B. bovis growth in high concentrations (Fig. 6A and B), suggesting that XP_001612131 
may not be involved in parasite invasion or rRmcystatin-1b is inhibiting unspecifically 
other B. bovis cysteine peptidases. It is important to note that the B. bovis experiments 
performed in this study try to mimic the parasite-vertebrate host interaction, in which the 
importance of cysteine peptidases has already been shown (Carletti et al., 2016; Okubo 
et al., 2007). However, in P. falciparum, the importance of the cysteine protease falcipain-
1 for parasite development in the mosquito midgut was demonstrated (Eksi et al., 2004). 
Moreover, a cystatin from H. longicornis was found to be up-regulated in ticks fed on dogs 
infected with B. gibsoni compared to non-infected ones and the recombinant cystatin was 
also able to inhibit B. bovis growth in culture (Zhou et al., 2006). Taken together, these 
data suggest a potential role of cysteine peptidases during parasite-vector interaction, in 
which vector cystatins may play a role during parasite proliferation in order to avoid 
deleterious effects to the tick (Florin-Christensen and Schnittger, 2009).  
In this study, we described the functional characterization of a novel type 1 cystatin from 
the tick R. microplus. Altogether our data suggested the involvement of Rmcystatin-1b in 
the regulation of cathepsin L-Like peptidases in the later phase of blood digestion, and a 
possible role in the interaction with the tick-borne hemoparasite B. bovis.  
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Table 1. Biochemical characterization of Rhipicephalus microplus Rmcystatin-1b 
inhibitory activity. 
 
Enzyme Ki (nM) 
BmCL1 0.013 
Papain 0.72 
Cathepsin L 0.41 
Cathepsin B 6.27 











Figure 1: Rmcystatin-1b primary structure analysis. (A) Alignment of amino acid 
sequence of Rhipicephalus microplus Rmcystatin-1b (MH378687) with other type 1 
cystatins from ticks; Dermacentor variabilis (ACF35512.1), Rhipicephalus 
haemaphysaloides (AIZ78005.1), Haemaphysalis longicornis (ABZ89553.1), R. 
haemaphysaloides (AIZ78005.1), R. microplus (ABG36931.1) and Ixodes scapularis 
(AAY66864.1). Identical residues are black boxed and the residues relevant for the 
inhibitory activity are indicated by arrows. (B) Phylogenetic analysis of type 1 and 2 
cystatins from the ticks H. longicornis, I. scapularis, D. variabilis and R. microplus. 
Rmcystatin-1b is indicated by an arrow. 
Figure 2: Localization of Rhipicephalus microplus Rmcystatin-1b transcripts in different 
tick tissues by RT-qPCR. Relative quantification or Rmcystatin-1b transcripts in the cDNA 
of (A) partially engorged ticks was determined in relation to the salivary glands and in (B) 
fully engorged ticks, in relation to hemocyte preparations. (C) Modulation of Rmcystatin-
1b transcripts in tick midgut at different hours post-detachment (hpd) in relation to partially 
engorged (PF) ticks. The averages ± SEM of four replicates are shown (* p < 0.05).  
Figure 3: Expression and purification of Rhipicephalus microplus rRmcystatin-1b. (A) Ion 
exchange chromatography with a HiPrep Q resin. Proteins were eluted using a linear 
gradient of 25 mM Tris-HCl buffer pH 8.0 containing 1.0 M NaCl (buffer B). (B) Size 
exclusion chromatography using a Superdex 75 columm. Arrows indicate the fractions in 
which inhibitory activity towards human cathepsin L was detected. (C) SDS-PAGE 15% 
of (1) non-induced bacteria, (2) IPTG-induced bacteria, (3) supernatant from bacterial 
lysate, (4) pooled protein from ion exchange and (5) pooled protein from size exclusion 
chromatography. 
Figure 4: Characterization of proteolytic activity of Rhipicephalus microplus midgut. (A) 
Proteolytic activity against typical cysteine peptidases substrates using midguts from 
different hpd. Proteolytic activity of midgut from 48 and 120 hpd were assayed in the 









Figure 5: Rhipicephalus microplus Rmcystatin-1b gene knock-down by RNA 
interference. (A) Relative quantification of Rmcystatin-1b transcripts in the midgut of ticks 
at 96 hpd. (B) Proteolytic activity of the midguts towards Z-FR-AMC and (C) Z-RR-AMC. 
Mann-Whitney test revealed significant statistical difference with p = 0.0087. Bars 
represent the averages ± SEM from 6 independent samples.  
Figure 6: Rhipicephalus microplus Rmcystatin-1b and Babesia bovis growth (A): Effect 
of different concentrations of rRmcystatin-1b in B. bovis S2P strain growth in vitro after 
72 h of treatment and (B) parasite growth curve during treatment with rRmcystatin-1b (25 
µM), parasitemia was determined at 24, 48 and 72 h by microscopic observation of 
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